Search research articles
Contact Us
Filters
Showing results (141-150 of 207) with videos related to
Page
of 21
Sort By:
JAMA Dermatology
|
October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
BMJ Open
|
July 8, 2021
Safety of topical corticosteroids in atopic eczema: an umbrella review
Emma Axon, Joanne R Chalmers, Miriam Santer, et al.
Journal of the American Academy of Dermatology
|
January 12, 2020
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Cancer Research
|
July 3, 2024
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer
Young A Yoo, Songhua Quan, William Yang, et al.
Cancer Research
|
February 27, 2021
Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
Kenji Unno, Zachary R Chalmers, Sahithi Pamarthy, et al.
The British Journal of Dermatology
|
March 1, 2007
To freeze or not to freeze: a cost-effectiveness analysis of wart treatment
M R Keogh-Brown, R J Fordham, K S Thomas, et al.
The British Journal of Dermatology
|
May 11, 2018
Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative
E E Grinich, J Schmitt, D Küster, et al.
Skin Health and Disease
|
June 6, 2022
Do patient characteristics matter when calculating sample size for eczema clinical trials?
L Howells, S Gran, J R Chalmers, et al.
The British Journal of Dermatology
|
November 19, 2016
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
P I Spuls, L A A Gerbens, E Simpson, et al.
The Veterinary Record
|
August 19, 1999
Orf (contagious pustular dermatitis) in farmworkers: prevalence and risk factors in three areas of England
G A Paiba, D R Thomas, K L Morgan, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 207) with videos related to
Sort By:
Page
of 21
JAMA Dermatology
|
October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
BMJ Open
|
July 8, 2021
Safety of topical corticosteroids in atopic eczema: an umbrella review
Emma Axon, Joanne R Chalmers, Miriam Santer, et al.
Journal of the American Academy of Dermatology
|
January 12, 2020
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Cancer Research
|
July 3, 2024
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer
Young A Yoo, Songhua Quan, William Yang, et al.
Cancer Research
|
February 27, 2021
Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer
Kenji Unno, Zachary R Chalmers, Sahithi Pamarthy, et al.
The British Journal of Dermatology
|
March 1, 2007
To freeze or not to freeze: a cost-effectiveness analysis of wart treatment
M R Keogh-Brown, R J Fordham, K S Thomas, et al.
The British Journal of Dermatology
|
May 11, 2018
Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative
E E Grinich, J Schmitt, D Küster, et al.
Skin Health and Disease
|
June 6, 2022
Do patient characteristics matter when calculating sample size for eczema clinical trials?
L Howells, S Gran, J R Chalmers, et al.
The British Journal of Dermatology
|
November 19, 2016
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
P I Spuls, L A A Gerbens, E Simpson, et al.
The Veterinary Record
|
August 19, 1999
Orf (contagious pustular dermatitis) in farmworkers: prevalence and risk factors in three areas of England
G A Paiba, D R Thomas, K L Morgan, et al.
Page
of 21